Metastatic Prostate Cancer Responds to Novel Radiation Therapy

By targeting prostate-specific membrane antigen, a molecule radiolabeled with lutetium-177 is expected to deliver high doses of beta radiation to distant metastases.

from Latest articles from Cancer Therapy Advisor News http://bit.ly/2tmNShR